Hasso Scholz

Q: What Schools Are Affiliated With Hasso Scholz

Hasso Scholz is affiliated with the following schools: Hannover Medical School, University of Hamburg, University of Bonn

Hasso Scholz's AcademicInfluence.com Rankings

Hasso Scholz

Medical

#3069

World Rank

#3521

Historical Rank

Pharmacology

#362

World Rank

#413

Historical Rank

medical Degrees

Download Badge

Medical

Hasso Scholz's Degrees

PhD Pharmacology University of Bonn
Doctorate Pharmacy University of Bonn

Why Is Hasso Scholz Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Hasso Scholz's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Three‐dimensional reconstitution of embryonic cardiomyocytes in a collagen matrix: a new heart muscle model system (1997) (591)
The regulation of the calcium conductance of cardiac muscle by adrenaline. (1977) (459)
A study of the ion selectivity and the kinetic properties of the calcium dependent slow inward current in mammalian cardiac muscle. (1977) (348)
INCREASE IN MYOCARDIAL Gi-PROTEINS IN HEART FAILURE (1988) (323)
The effect of the internal sodium concentration on calcium fluxes in isolated guinea‐pig auricles (1970) (313)
Increased expression of cardiac phosphatases in patients with end-stage heart failure. (1997) (261)
Activity of cAMP-dependent protein kinase and Ca2+/calmodulin-dependent protein kinase in failing and nonfailing human hearts. (1999) (243)
STEERING COMMITTEE AND INVESTIGATORS OF THE LEVOSIMENDAN INFUSION VERSUS DOBUTAMINE (LIDO) STUDY. EFFICACY AND SAFETY OF INTRAVENOUS LEVOSIMENDAN COMPARED WITH DOBUTAMINE IN SEVERE LOWOUTPUT HEART FAILURE (THE LIDO STUDY): A RANDOMISED DOUBLEBLIND TRIAL (2002) (235)
Increased messenger RNA level of the inhibitory G protein alpha subunit Gi alpha-2 in human end-stage heart failure. (1992) (217)
Endotoxin and cytokines induce direct cardiodepressive effects in mammalian cardiomyocytes via induction of nitric oxide synthase. (1996) (175)
Messenger RNA expression and immunological quantification of phospholamban and SR-Ca(2+)-ATPase in failing and nonfailing human hearts. (1996) (171)
Inotropic drugs and their mechanisms of action. (1984) (150)
Cardiac glycoside receptor, (Na+ + K+)-ATPase activity and force of contraction in rat heart. (1980) (131)
Existence and functional role of alpha 1-adrenoceptors in the mammalian heart. (1985) (131)
Carvedilol therapy in pediatric patients with congestive heart failure: a study investigating clinical and pharmacokinetic parameters. (2002) (130)
Effects of α‐adrenoceptor stimulation with phenylephrine in the presence of propranolol on force of contraction, slow inward current and cyclic AMP content in the bovine heart (1984) (129)
Alpha-1 adrenoceptor-mediated positive inotropic effect and inositol trisphosphate increase in mammalian heart. (1988) (126)
Effects of Beta- and Alpha-Adrenoceptor Activators and Adrenergic Transmitter Releasing Agents on the Mechanical Activity of the Heart (1980) (124)
Muscarinic and β-adrenergic regulation of heart rate, force of contraction and calcium current is preserved in mice lacking endothelial nitric oxide synthase (1999) (121)
Adenosine inhibition of catecholamine-induced increase in force of contraction in guinea-pig atrial and ventricular heart preparations. Evidence against a cyclic AMP- and cyclic GMP-dependent effect. (1984) (117)
Alpha-adrenoceptor-mediated positive inotropic effect of phenylephrine in isolated human ventricular myocardium. (1984) (116)
Evidence for physiological functions of protein phosphatases in the heart: evaluation with okadaic acid. (1993) (115)
Radioimmunochemical quantification of Gi alpha in right and left ventricles from patients with ischaemic and dilated cardiomyopathy and predominant left ventricular failure. (1994) (114)
Cardiac effects of adenosine and adenosine analogs in guinea-pig atrial and ventricular preparations: evidence against a role of cyclic AMP and cyclic GMP. (1985) (109)
Evidence for isoproterenol-induced phosphorylation of phosphatase inhibitor-1 in the intact heart. (1991) (109)
Expression of inducible nitric oxide synthase in failing and non-failing human heart. (1996) (105)
Basal and isoprenaline-stimulated cAMP content in failing versus nonfailing human cardiac preparations. (1989) (98)
Increased expression of constitutive nitric oxide synthase III, but not inducible nitric oxide synthase II, in human heart failure. (1998) (93)
Phosphodiesterase-inhibiting properties of newer inotropic agents. (1986) (90)
Pharmacological aspects of calcium channel blockers (2004) (89)
Effects of metoprolol on myocardial β-adrenoceptors and Giα-proteins in patients with congestive heart failure (1996) (88)
Nitric Oxide Activates the β2 Subunit of Soluble Guanylyl Cyclase in the Absence of a Second Subunit* (2001) (88)
Positive inotropism of vanadate in cat papillary muscle (1978) (85)
Reduced α1‐ and β2‐adrenoceptor‐mediated positive inotropic effects in human end‐stage heart failure (1992) (84)
Cellular and molecular aspects of contractile dysfunction in heart failure. (1998) (82)
Cardiac α1‐adrenoceptor densities in different mammalian species (1992) (78)
Vanadate and its significance in biochemistry and pharmacology. (1984) (77)
Muscarinic and beta-adrenergic regulation of heart rate, force of contraction and calcium current is preserved in mice lacking endothelial nitric oxide synthase. (1999) (75)
Isoprenaline stimulates gene transcription of the inhibitory G protein alpha-subunit Gi alpha-2 in rat heart. (1993) (70)
Long term beta-adrenoceptor-mediated up-regulation of Gi alpha and G(o) alpha mRNA levels and pertussis toxin-sensitive guanine nucleotide-binding proteins in rat heart. (1992) (69)
Purified cardiac cell membranes with high (Na+ + K+) ATPase activity contain significant NADH-vanadate reductase activity (1979) (68)
Evidence for alpha 1-adrenoceptor-mediated increase of inositol trisphosphate in the human heart. (1989) (65)
Mechanisms of the contractile effects of levosimendan in the mammalian heart. (1997) (65)
Protein phosphorylation in isolated trabeculae from nonfailing and failing human hearts (2004) (63)
Preserved Frank-Starling mechanism in human end stage heart failure. (1998) (63)
Increase in IP3 precedes alpha-adrenoceptor-induced increase in force of contraction in cardiac muscle. (1987) (63)
On the cardiac contractile, biochemical and electrophysiological effects of cantharidin, a phosphatase inhibitor. (1995) (62)
Phosphodiesterase inhibition and positive inotropic effects. (1989) (62)
Pertussis toxin does not inhibit the alpha 1-adrenoceptor-mediated effect on inositol phosphate production in the heart. (1987) (55)
Effects of carbachol and (−)‐N6‐phenylisopropyladenosine on myocardial inositol phosphate content and force of contraction (1990) (55)
Functional evidence for the existence of adenosine receptors in the human heart. (1985) (55)
Effects of α- and β-adrenergic agonists, phosphodiesterase inhibitors and adenosine on isolated human heart muscle preparations (1987) (54)
Differential regulation of mRNA specific for beta 1- and beta 2-adrenergic receptors in human failing hearts. Evaluation of the absolute cardiac mRNA levels by two independent methods. (1996) (51)
Relation between contractile function and regulatory cardiac proteins in hypertrophied hearts. (1996) (50)
Receptor mechanisms involved in the 5‐HT‐induced inotropic action in the rat isolated atrium (1998) (49)
Increased myocardial α1adrenoceptor density in rats chronically treated with propranolol (1985) (49)
Ca(++)-dependent constitutive nitric oxide synthase is not involved in the cyclic GMP-increasing effects of carbachol in ventricular cardiomyocytes. (1993) (48)
Biochemical and electrophysiological mechanisms of the positive inotropic effect of calyculin A, a protein phosphatase inhibitor. (1994) (45)
Effects of the benzimidazole derivatives pimobendan and 2-(4-hydroxy-phenyl)-5-(5-methyl-3-oxo-4,5-dihydro-2H-6- pyridazinyl) benzimidazole . HCl on phosphodiesterase activity and force of contraction in guinea-pig hearts. (1985) (44)
Relation of positive inotropic and chronotropic effects of pimobendan, UD-CG 212 Cl, milrinone and other phosphodiesterase inhibitors to phosphodiesterase III inhibition in guinea-pig heart (1989) (44)
Stimulatory (insulin-mimetic) and inhibitory (ouabain-like) action of vanadate on potassium uptake and cellular sodium and potassium in heart cells in culture. (1982) (43)
Pharmacological characterization of A2-adenosine receptors in guinea-pig ventricular cardiomyocytes. (1994) (42)
Distinct down-regulation of cardiac β1- and β2-adrenoceptors in different human heart diseases (1991) (41)
Chronic treatment with carbachol sensitizes the myocardium to cAMP-induced arrhythmia. (1996) (40)
Inactivation of GiαProteins Increases Arrhythmogenic Effects ofβ-Adrenergic Stimulation in the Heart (1998) (39)
Pharmacological characterization of protein phosphatase activities in preparations from failing human hearts. (1999) (39)
Long-term beta adrenoceptor-mediated alteration in contractility and expression of phospholamban and sarcoplasmic reticulum Ca(++)-ATPase in mammalian ventricle. (1998) (39)
Developmental changes of nitric oxide-sensitive guanylyl cyclase expression in pulmonary arteries. (2001) (38)
Reduction of myocardial myoglobin in bovine dilated cardiomyopathy. (1997) (37)
Role of guanine nucleotide-binding protein in the regulation by adenosine of cardiac potassium conductance and force of contraction. Evaluation with pertussis toxin (1986) (37)
Determination of carvedilol in human cardiac tissue by high-performance liquid chromatography. (2001) (37)
Effects of adenosine receptor and muscarinic cholinergic receptor agonists on cardiac protein phosphorylation. Influence of pertussis toxin. (1994) (35)
Evidence for the existence of inositol tetrakisphosphate in mammalian heart. Effect of alpha 1-adrenoceptor stimulation. (1990) (35)
Calcium sensitization as new principle of inotropic therapy in end-stage heart failure? (1998) (33)
Small blood volumes from children for quantitative sotalol determination using high-performance liquid chromatography. (2001) (32)
Differential antagonism by 1,3-dipropylxanthine-8-cyclopentylxanthine and 9-chloro-2-(2-furanyl)-5,6-dihydro-1,2,4-triazolo(1,5-c)quinazolin-5-im ine of the effects of adenosine derivatives in the presence of isoprenaline on contractile response and cyclic AMP content in cardiomyocytes. Evidence for (1990) (31)
Apparent up‐regulation of stimulatory G‐protein α subunits in the pregnant human myometrium is mimicked by elevated smoothelin expression 1 (2000) (30)
Phosphodiesterase inhibition in ventricular cardiomyocytes from guinea‐pig hearts (1992) (30)
Isoprenaline-induced increase in the 40/41 kDa pertussis toxin substrates and functional consequences on contractile response in rat heart (2004) (29)
Myocardial alpha-adrenoceptors and positive inotropy. (1986) (29)
Beta-adrenoceptor stimulation-induced increase in cardiac Gi-protein expression and in carbachol sensitivity. (1991) (28)
Effects of metoprolol on myocardial beta-adrenoceptors and Gi alpha-proteins in patients with congestive heart failure. (1996) (28)
Positive inotropic effects of the calcium sensitizer CGP 48506 in failing human myocardium. (1996) (28)
Stimulatory effect of vanadate on cyclic AMP levels in cat papillary muscle. (1980) (28)
Stimulatory effect of vanadate on (Na+ + K+)-ATPase activity and on 3H-ouabain-binding in a cat heart cell membrane preparation (1979) (27)
Increased responsiveness to stimulation of alpha- but not beta-adrenoceptors in the hereditary cardiomyopathy of the Syrian hamster. Intact adenosine- and cholinoceptor-mediated isoprenaline antagonistic effect. (1986) (27)
Expression and tissue localization of soluble guanylyl cyclase in the human placenta using novel antibodies directed against the alpha(2) subunit. (2001) (27)
Regional distribution of β1- and β2-adrenoceptors in the failing and nonfailing human heart (2004) (27)
Effects of Isomazole on Force of Contraction and Phosphodiesterase Isoenzymes I‐IV in Nonfailing and Failing Human Hearts (1991) (27)
Bovine hereditary cardiomyopathy: an animal model of human dilated cardiomyopathy. (1995) (27)
Positive inotropic effect of carbachol and inositol phosphate levels in mammalian atria after pretreatment with pertussis toxin. (1990) (27)
Expression of nitric oxide-sensitive guanylyl cyclase subunits in human corpus cavernosum. (2000) (27)
Effect of vanadium in the +5, +4 and +3 oxidation states on cardiac force of contraction, adenylate cyclase and (Na+ + K+)-ATPase activity. (1982) (27)
Existence and alpha 1-adrenergic stimulation of inositol polyphosphates in mammalian heart. (1992) (26)
Characterization of biochemical effects of CGS 21680C, an A2-adenosine receptor agonist, in the mammalian ventricle. (1997) (26)
Mechanism underlying the reduced positive inotropic effects of the phosphodiesterase III inhibitors pimobendan, adibendan and saterinone in failing as compared to nonfailing human cardiac muscle preparations (1991) (26)
Pertussis toxin unmasks stimulatory myocardial A2-adenosine receptors on ventricular cardiomyocytes. (1993) (26)
High Selectivity for Inhibition of Phosphodiesterase III and Positive Inotropic Effects of MCI‐154 in Guinea Pig Myocardium (1993) (25)
Pharmacological actions of various inotropic agents. (1983) (25)
HPLC quantification of carvedilol in small plasma volumes from children (2001) (25)
Interaction of beta-adrenoceptor and adenosine receptor agonists on phosphorylation. Identification of target proteins in mammalian ventricles. (1995) (24)
The role of alpha 1-adrenergic and muscarinic receptors in cardiac function. (1991) (24)
Time course and extent of α1‐adrenoceptor density changes in rat heart after β‐adrenoceptor blockade (1989) (24)
Mechanisms of the contractile effects of 2,3-butanedione-monoxime in the mammalian heart (1996) (24)
Cardiac alpha 1-adrenoceptor densities in different mammalian species. (1992) (23)
Possible role of cyclic AMP in the relaxation process of mammalian heart: Effects of dibutyryl cyclic AMP and theophylline on potassium contractures in cat papillary muscles (1976) (23)
Stimulatory effects of DB-c-AMP and adrenaline on myocardial contraction and 45Ca exchange. Experiments at reduced calcium concentration and low frequencies of stimulation (2004) (22)
Positive inotropic effects of the calcium sensitizer CGP 48506 in guinea pig myocardium. (1996) (22)
Effects of 1,3-dipropyl-8-cyclopentylxanthine (DPCPX), a highly selective adenosine receptor antagonist, on force of contraction in guinea-pig atrial and ventricular cardiac preparations (1989) (22)
Localization of preproenkephalin mRNA in rat heart: selective gene expression in left ventricular myocardium. (1998) (22)
In Vivo β-Adrenergic Stimulation Leads to Biphasic Regulation of Giα-2 Gene Transcriptional Activity in Rat Heart (1994) (22)
Interaction between sotalol and an antacid preparation. (1997) (21)
Phosphodiesterase inhibition and positive inotropy in failing human myocardium. (1992) (21)
Adenosine inhibits the positive inotropic effect of 3‐isobutyl‐1‐methylxanthine in papillary muscles without effect on cyclic AMP or cyclic GMP (1988) (21)
Decrease in β1- and increase in β2-adrenoceptors in long-term follow-up after orthotopic cardiac transplantation (1992) (21)
Influence of cyclization and acyl substitution on the inotropic effects of adenine nucleotides (2004) (21)
The technique of endobronchial lidocaine administration does not influence plasma concentration profiles and pharmacokinetic parameters in humans. (1995) (18)
RELATIONSHIP BETWEEN THEOPHYLLINE UPTAKE AND INOTROPIC EFFECT IN THE GUINEA‐PIG HEART (1974) (17)
Positive inotropic agents: Different mechanisms of action (1986) (17)
The positive inotropic effect of phenylephrine in the presence of propranolol. Increase in time to peak force and in relaxation time without increase in c-AMP (1978) (16)
Regulation and possible functional implications of G-protein mRNA expression in nonfailing and failing ventricular myocardium. (1992) (16)
Isoprenaline-induced increase in mRNA levels of inhibitory G-protein α-subunits in rat heart (1991) (16)
Molecular and Cellular Mechanisms of Cardiovascular Regulation (1996) (15)
Effects of the phosphatase inhibitor calyculin A on the phosphorylation of C-protein in mammalian ventricular cardiomyocytes. (1995) (15)
Positive inotropic effect of bay K 8644: cAMP-independence and lack of inhibitory effect of adenosine (1985) (15)
Enrichment of G protein α-subunit mRNAs in the AV-conducting system of the mammalian heart (1995) (14)
Effects of adenosine analogues on contractile response and CAMP content in guinea-pig isolated ventricular myocytes (1989) (14)
Effectiveness of theophylline to increase cyclic AMP levels and force of contraction in electrically paced guinea-pig auricles. Comparison with isoprenaline, calcium and ouabain (1977) (14)
Positive inotropic effects of digitoxin- and digoxin-glucuronide in human isolated ventricular heart muscle preparations. (1984) (14)
Mechanism of action and cardiotonic activity of a new phosphodiesterase inhibitor, the benzimidazole derivative adibendan (BM 14.478), in guinea-pig hearts (1988) (14)
Glyceryl trinitrate treatment up-regulates soluble guanylyl cyclase in rat dura mater (2001) (14)
Dibutyryl cyclic AMP and adrenaline increase contractile force and 45Ca uptake in mammalian cardiac muscle (2004) (13)
Effect of papaverine on cyclic AMP, calcium uptake and force of contraction in isolated guinea-pig auricles. (1977) (13)
Evidence for adenosine receptor-mediated isoprenaline-antagonistic effects of the adenosine analogs PIA and NECA on force of contraction in guinea-pig atrial and ventricular cardiac preparations (1985) (13)
Comparison of the Stereoselective Effects of a Thiadiazinone Derivative on Contractile Parameters and Protein Phosphorylation in the Mammalian Ventricle (1995) (13)
Sodium fluoride attenuates the negative inotropic effects of muscarinic M2 and adenosine receptor agonists. (1995) (12)
Selective inhibition of cAMP phosphodiesterase III activity by the cardiotonic agent saterinone in guinea pig myocardium. (1988) (12)
Classification and mechanism of action of antiarrhythmic drugs * (1994) (12)
Assignment of GUCY1B2, the gene coding for the beta2 subunit of human guanylyl cyclase to chromosomal band 13q14.3 between markers D13S168 and D13S155. (1999) (12)
Isoprenaline-induced increase in mRNA levels of inhibitory G-protein alpha-subunits in rat heart. (1991) (12)
[The positive ionotropic effect of dibutyryl-3',5'-AMP on isolated rat atria]. (1972) (12)
Possible involvement of inositol-lipid metabolism in malignant hyperthermia. (1991) (12)
The Expression Pattern of Nitric Oxide-sensitive Guanylyl Cyclase in the Rat Heart Changes During Postnatal Development (2002) (12)
Reduced alpha 1- and beta 2-adrenoceptor-mediated positive inotropic effects in human end-stage heart failure. (1992) (12)
The β2 subunit of nitric oxide-sensitive guanylyl cyclase is developmentally regulated in rat kidney (2001) (11)
Effects of the beta2-adrenoceptor agonists fenoterol and salbutamol on force of contraction in isolated human ventricular myocardium (1985) (11)
Digitoxin intoxication during concomitant use of amiodarone (1998) (11)
Does an impaired adenosine mediated feedback control play a role in the development of hereditary dystrophic cardiomyopathy? (1986) (11)
Inotropic drugs in the treatment of heart failure. (1984) (11)
Evidence for α1-Adrenoceptor‐Mediated Increase of Inositol Trisphosphate in the Human Heart (1989) (11)
Enhanced pulmonary expression of the TrkB neurotrophin receptor in hypoxic rats is associated with increased acetylcholine‐induced airway contractility (2009) (10)
New positive inotropic agents acting by phosphodiesterase inhibition or alpha 1-adrenergic stimulation. (1989) (10)
Assignment1 of GUCY1A3, a candidate gene for hypertension, to human chromosome bands 4q31.1→q31.2 by in situ hybridization (2000) (10)
Evidence against a role of a pertussis toxin-sensitive guanine nucleotide-binding protein in the alpha1-adrenoceptor-mediated positive inotropic effect in the heart (1987) (10)
Effect of DB-c-AMP on mechanical characteristics of ventricular and atrial preparations of several mammalian species (2004) (10)
Mechanism of the "Antiadrenergic" Effects of Adenosine on Myocardial Force of Contraction (1987) (10)
Effects of the triazolopyrimidine trapidil on force of contraction, beating frequency and phosphodiesterase I--IV activity in guinea-pig hearts. (1991) (10)
Inactivation of (Gialpha) proteins increases arrhythmogenic effects of beta-adrenergic stimulation in the heart. (1998) (10)
Determination of sotalol in human cardiac tissue by high-performance liquid chromatography. (1996) (10)
Importance of cardiac cell membranes in vanadate-induced NADH oxidation (1981) (10)
Effects of adenosine analogues on force and cAMP in the heart. Influence of adenosine deaminase. (1989) (9)
Localization of preproenkephalin mRNA in rat heart: selective gene expression in left ventricular myocardium. (1998) (9)
Inhibition of the effects of adenosine on force of contraction and the slow calcium inward current by pertussis toxin is associated with myocardial lesions. (1988) (9)
Increased sensitivity to α-adrenoceptor stimulation but intact purinergic and muscarinergic effects in prehypertensive cardiac hypertrophy of spontaneously hypertensive rats (1986) (9)
Effects of vanadate on the c-AMP system of the heart (1980) (9)
Changes in cardiac β-Adrenoceptors in human heart diseases: Relationship to the degree of heart failure and further evidence for etiology-related regulation of β1 and β2 subtypes☆ (1993) (9)
DISSOCIATION OF THEOPHYLLINE UPTAKE AND INOTROPIC EFFECT IN MYOCARDIAL TISSUE: INFLUENCE OF TEMPERATURE, pH AND CALCIUM (1975) (8)
On the mechanism of action of theophylline on the heart and other organs (1982) (8)
Effects of caffeine, halothane, succinylcholine, phenylephrine and isoproterenol on myocardial force of contraction of malignant hyperthermia susceptible swine (1991) (8)
Effects of Beta‐ and Alpha‐adrenergic Agonists, Adenosine, and Carbachol in Heart Muscle Isolated from Malignant Hyperthermia Susceptible Swine (1988) (8)
Regulation of the human Giα-2 gene promotor activity in embryonic chicken cardiomyocytes (2004) (8)
Regional distribution of beta 1- and beta 2-adrenoceptors in the failing and nonfailing human heart. (1992) (7)
Receptor-Mediated Regulation of Cardiac Contractility: lnotropic Effects of Alpha-Adrenoceptor Stimulation with Phenylephrine and Noradrenaline in Failing Human Hearts (1996) (7)
Effect of captopril on myocardial β-adrenoceptor density and Giα-proteins in patients with mild to moderate heart failure due to dilated cardiomyopathy (2004) (7)
Enrichment of G protein alpha-subunit mRNAS in the AV-conducting system of the mammalian heart. (1995) (7)
Effect of captopril on myocardial beta-adrenoceptor density and Gi alpha-proteins in patients with mild to moderate heart failure due to dilated cardiomyopathy. (1995) (7)
Isoprenaline Stimulates Gene Transcription of the Inhibitory G Protein a-Subunit G . ia-2 in Rat Heart (2005) (7)
Cardiac alpha-receptors and cardiac hypertrophy in genetic predisposition to hypertension. (1986) (6)
Effects of saterinone and its enantiomers R(+)-saterinone and S(−)-saterinone on the phosphodiesterase isoenzymes from ventricular tissue of failing human hearts and porcine hearts (1994) (6)
Phosphodiesterase III inhibition by MCI-154 and other cardiotonic drugs in relation to force of contraction, cAMP content and calcium sensitization in the heart (1990) (6)
Adenosine and adenosine analogs inhibit phosphodiesterase activity in the heart (1984) (6)
Increased myocardial alpha 1 adrenoceptor density in rats chronically treated with propranolol. (1985) (6)
Inotropic actions of adenosine derivatives in the mammalian heart (1993) (5)
Mechanisms of positive inotropic effects. (1989) (5)
Quantitation of diltiazem in human cardiac tissue using high-performance liquid chromatography. (1997) (5)
Distinct down-regulation of cardiac beta 1- and beta 2-adrenoceptors in different human heart diseases. (1991) (5)
Efficacy and safety of intravenous levosimendan in severe low-output heart failure. A randomized, double-blind comparison to dobutamine (The LIDO-Study) (1999) (5)
On the mechanism of the cardiotonic and smooth muscle relaxing effects of the methylxanthines (1984) (5)
[Mechanism of the positive inotropic effect of phosphodiesterase inhibitors]. (1991) (5)
Regulation of the human Gi alpha-2 gene promotor activity in embryonic chicken cardiomyocytes. (1996) (5)
Effects of Isoprenaline on Force of Contraction, cAMP Content, and Phosphorylation of Regulatory Proteins in Hearts from Chronic β‐Adrenergic‐Stimulated Rats a (1995) (5)
Evidence for a dibutyryl-c-AMP increased 45Ca release from cardiac muscle. (1975) (5)
Deferoxamine blocks interactions of fluoride and carbachol in isolated mammalian cardiac preparations. (1998) (5)
Failure of reserpinization to decrease the positive inotropic effect of dibutyryl cyclic AMP. (1973) (5)
Biochemical changes in malignant hyperthermia susceptible swine: cyclic AMP, inositol phosphates, alpha 1, beta 1- and beta 2-adrenoceptors in skeletal and cardiac muscle. (1993) (5)
Inotropic response in CHF: myocarditis vs dilated cardiomyopathy. (1988) (5)
Dissociation of the effects of forskolin and dibutyryl cAMP on force of contraction and phospholamban phosphorylation in human heart failure. (1999) (5)
Changes in cardiac beta 1- and beta 2-adrenoceptor densities after human cardiac transplantation: relation to transplant coronary vasculopathy and pretransplantation disease. (1992) (5)
Adrenaline, DB-c-AMP and myocardial 45Ca exchange. Comparative studies in rat and guinea-pig auricles (2004) (5)
Effects of and 13-adrenergic agonists, phosphodiesterase inhibitors and adenosine on isolated human ( Humans 1 heart muscle v. preparations Animals (1987) (4)
Mechanisms of the contractile effects of flosequinoxan (1995) (4)
The influence of intracellular sodium concentration on calcium influx in isolated guinea-pig auricles (2006) (4)
No differences in benzo(a)pyrene hydroxylase activity in the human immature placenta and in the human fetal liver from cigarette smoking and nonsmoking women (1974) (4)
The Pharmacology of Propafenone (1983) (4)
Positive inotropic but no relaxant effects of phenylephrine in cat papillary muscle. (1978) (4)
Functional evidence against the existence of β2-adrenoceptors mediating positive inotropic effects in guinea-pig right ventricular myocardium (1996) (4)
Increased myocardial Alpha-1-adrenoceptor density in rats treated with propranolol via osmotic minipumps (1986) (3)
Effect of vanadate on myocardial force of contraction (1980) (3)
Negative inotropic effect of vanadate in ventricular myocardium in the presence of 3-isobutyl-1-methylxanthine or isoprenaline (2004) (3)
ADRENALINE, ADENOSINE, AND FEEDBACK (1985) (3)
Negative inotropic effects of aldosterone antagonists in isolated human and guinea-pig ventricular heart muscle (1984) (3)
Different effects of positive inotropic agents on cAMP content, force of contraction and phosphodiesterase activity in failing and nonfailing human hearts (1989) (3)
Effects of cyclosporine on protein phosphorylation in the heart. (1994) (3)
Time course and extent of alpha 1-adrenoceptor density changes in rat heart after beta-adrenoceptor blockade. (1989) (3)
Effect of a “therapeutic” concentration of digitoxigenine on myocardial potassium and sodium content in Ca-poor media (2004) (3)
Proceedings: Cyclic AMP and alterations in inotropic state in isolated guinea pig auricles. (1975) (2)
Pharmacological profile of CGP 48506, a new positive inotropic agent (1997) (2)
Susumu Ohno left us January 13, 2000, at the age of 71 (2000) (2)
Evidence against a role of (Na++K+-ATPase in the alpha-adrenoceptor mediated positive inotropic effect of phenylephrine (1980) (2)
Pertussis toxin prevents adenosine receptor- and m-cholinoceptor-mediated sinus rate slowing and AV conduction block in the guinea-pig heart (2004) (2)
Response of isolated human ventricular myocardium to cyclic AMP and its dibutyryl derivative (1974) (2)
On the mechanism of positive inotropic effects of alpha-adrenoceptor agonists (2007) (2)
[Changes in gene expression in terminal myocardial failure]. (1992) (2)
Introduction: Mechanisms of positive inotropic effects (1989) (2)
Decrease in beta 1- and increase in beta 2-adrenoceptors in long-term follow-up after orthotopic cardiac transplantation. (1992) (2)
Effects of PIA and NECA on contractile behaviour and cAMP content in isolated cardiomyocytes in the presence of the A1-adenosine receptor antagonist DPCPX☆ (1989) (2)
[Ca-dependent membrane potential changes in the heart and their significance for electro-mechanical coupling. Experiments with tetrodotoxin in Na-containing solutions]. (1969) (2)
Effect of theophylline on calcium exchangeability in ventricular myocardium (2004) (2)
Reduced a1- and fl2-adrenoceptor-mediated positive inotropic effects in human end-stage heart failure (2006) (1)
Effects on transmembrane action potential, slow inward current and force of contraction in ventricular cardiac muscle of BRL 31660, a new antiarrhythmic drug with class I and class IV activity (1985) (1)
Proceedings: Inability of propranolol to change the effects of theophylline on myocardial mechanics. (1975) (1)
[Phosphodiesterase inhibition as a therapeutic principle]. (1994) (1)
[On the influence of the extracellular Ca concentration on membrane potential and contraction of isolated heart preparations during graded depolarization]. (1968) (1)
Increased sensitivity to alpha-adrenoceptor stimulation but intact purinergic and muscarinergic effects in prehypertensive cardiac hypertrophy of spontaneously hypertensive rats. (1986) (1)
Beta-adrenergic receptor number in surgically denervated, transplanted human hearts. (1992) (1)
EFFECTS OF ALPHA- AND BETA-ADRENOCEPTOR AGONISTS, ADENOSINE OR CARBACHOL ON VENTRICULAR HEART PREPARATIONS OF MALIGNANT HYPERTHERMIA SUSCEPTIBLE SWINE (1986) (1)
Adrenoceptors in the Myocardium: Mechanical and Biochemical Events Resulting from Their Stimulation (1986) (1)
Inotropic Stimulation and Myocardial Energetics (1989) (1)
G protein mRNA in left ventricular hypertrophy and heart failure (1992) (1)
[Malignant hyperthermia and inositol phosphate metabolism in the heart and skeletal musculature]. (1991) (1)
In vivo beta-adrenergic stimulation leads to biphasic regulation of Gi alpha-2 gene transcriptional activity in rat heart. (1994) (1)
Usefulness of increased myocardial cyclic adenosine 3',5'-monophosphate content as a sign of rejection after cardiac transplantation. (1995) (1)
Effects of (−)-Phenylephrine on force of contraction in the presence of cocaine and hydrocortisone in cat papillary muscle (1984) (1)
Isoprenaline-like effects of the phosphodiesterase inhibitor 3-isobutyl-1-methylxanthine on mechanical, biochemical and electrophysiological parameters in the mammalian heart (1985) (1)
[Ca-dependent changes in membrane potential and cardiac contraction under the influence of adrenaline and digitoxigenin]. (1970) (1)
Phosphorylation of phospholamban and troponin I in failing human heart (1992) (1)
Proceedings: Uptake and release of 3H-theophylline in isolated perfused guinea-pig hearts. (1974) (0)
ß-ADRENOCEPTOR DENSITY IN DIFFERENT HUMAN HEART DISEASES AND RELATIONSHIP TO THE DEGREE OF HEART FAILURE (1991) (0)
[Interaction of digitoxigenin, norepinephrine and calcium during hypothermia in isolated mammalina heart preparations]. (1968) (0)
Characterization of the phosphodiesterase inhibition by 2-(3-methoxy-5-methylsulfinyl-2-thienyl)-1H-imidazo-(4,5-c)-pyridine HCl and its sulfide- and sulfone derivatives in myocardial preparations from failing human hearts. (1995) (0)
Effects of the Beta-Adrenoceptor Blocker Carvedilol in Children with Myocardial Failure (2003) (0)
[Pharmacology of positive inotropically acting drugs]. (1982) (0)
[Electrophysiological experiments on the action of tetrodotoxin on the heart]. (1969) (0)
Inotropic effects of adenosine and 5'-N-ethylcarboxamideadenosine and inositol trisphosphate levels in mammalian heart (1990) (0)
[Pharmacology of heart failure-relevant substance groups]. (1990) (0)
The Influence of Mn++-Ions on the positive inotropic effects of some drugs in isolated guinea-pig auricles (1969) (0)
[Drug therapy of cardiovascular diseases. Heart failure. Introduction to the subject. Progress since 1982]. (1992) (0)
Subject Index Vol. 88, 2000 (2000) (0)
[Drug therapy in advanced age]. (1996) (0)
[Consensus conference "Therapy of chronic heart insufficiency" inaugurated by the Munich Collegium for Therapy Research e.V. together with the German Society for Cardiovascular Research]. (1993) (0)
[Therapy of arrhythmias. New anti-arrhythmia agents]. (1981) (0)
Effects of the alpha 1-adrenoceptor agonist phenylephrine in pig heart. Study of the direct action on contractile proteins. (1993) (0)
Changes in cardiac beta-adrenoceptors in human heart diseases: relationship to the degree of heart failure and further evidence for etiology-related regulation of beta 1 and beta 2 subtypes. (1993) (0)
[Mechanism of the positive ionotropic action of theophylline on the mammalian heart. 3. Effect of theophylline on contraction and Ca dependent changes in membrane potentials]. (1971) (0)
The effect of calcium and sodium ions on the potassium contracture of mammalian cardiac muscle (1969) (0)
Electro-physiological studies of the action of tetrodotoxin on the heart (1969) (0)
Regulation of EC-coupling by drugs and receptors. Alpha-adrenoceptors*1 (1992) (0)
Influence of adenosine receptor agonists and antagonists on cAMP-dependent protein kinase activity and contractility in guinea-pig papillary muscles (1990) (0)
[Therapy of biguanidine-induced lactate acidosis]. (1975) (0)
[On the effect of calcium and sodium on the potassium contracture of isolated guinea pig auricles]. (1969) (0)
Mechanical and Electrophysiological Effects of a-Adrenoceptor Stimulating Drugs in the Heart (1984) (0)
[Influence of divalent Mn ions on the positive inotropic effect of some drugs in isolated guinea pig atria]. (1969) (0)
[Influence of manganese ions on the positive inotropic effect of adrenaline, theophylline and digitoxigenin in isolated guinea pig atria]. (1969) (0)
[Aminophenazone induced agranulocytosis and intrahepatic cholestasis in a 12-year-old girl]. (1972) (0)
[Differences in contractural character of ventricular and atrial preparations from homoiotherm hearts]. (1969) (0)
Role of nitric oxide on the M-cholinoceptor-mediated increase in cGMP content and contractility in ventricular cardiomyocytes (1992) (0)
MECHANISMS OF ACTION (2005) (0)
[Effect of calcium and sodium ions on potassium contracture of the homoiotherm heart]. (1969) (0)
[Effect of dibutyryl-c-AMP on the contractile strength of the isolated human myocardial ventricle]. (1973) (0)
[On the relation between membrane potential and contraction in the heart under the influence of adrenaline]. (1968) (0)
[On interactions between digitoxigenin, noradrenaline and calcium on the myocardium]. (1968) (0)
Cardiac ai-adrenoceptor densities in different mammalian species (2006) (0)
Effects of Specific 3-H-Ouabain Binding to the Cardiac Glycoside Receptor on (Na + +K + )-ATPase Activity and on Force of Contraction in Rat Heart (1978) (0)
[Mechanism of the positive ionotropic action of theophylline on the mammalian heart. 2. Effect of theophylline on the uptake and release of 45 Ca]. (1971) (0)
The Influence of Intracellular Sodium Concentration on Calcium Influx in Isolated Guinea-Pig Auricles / Der Einfluß der intracellulären Natriumkonzentration auf den Calcium-influx in isolierte Meerschweinchenvorhöfe (1969) (0)
Evidence for M-cholinoceptor-mediated activation of cardiac phosphatases ☆ (1992) (0)
Contents Vol. 88, 2000 (2000) (0)
Time course and extent of a 1-adrenoceptor density changes in rat heart after f-adrenoceptor blockade ' (2006) (0)
Increased myocardial cAMP in patients with transplant coronary vasculopathy (1992) (0)
[Mechanism of the positive ionotropic action of theophylline on the mamalian heart. I. Influence of extracellular Ca, Na and K concentrations and of reserpine]. (1971) (0)
[Anti-arrhythmic and cardiodepressive effects of anti-arrhythmia agents]. (1988) (0)
[Treatment of heart failure--yesterday, today, tomorrow]. (1987) (0)
[Ventricular cardiac arrhythmias. New anti-arrhythmia agents]. (1996) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Hasso Scholz?

Hasso Scholz is affiliated with the following schools: